MCKESSON CORP (MCK)

777.27 1.83 (0.24%)

As of 2025-10-16 22:04:09 EST

McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".

Traded asNYSE: MCK
ISINUS58155Q1031
CIK0000927653
LEI549300WZWOM80UCFSF54
EIN943207296
SectorHealthcare
IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries
CEOBrian S. Tyler
Employees45,000
Fiscal Year End0331
Address6555 STATE HIGHWAY 161, IRVING, TX, 75039
Phone972-446-4800
Websitehttp://mckesson.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
MCKMCKESSON CORP2025-10-16 22:04:09777.271.830.24
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
MCK0000927653MCKESSON CORPUS58155Q1031549300WZWOM80UCFSF54943207296NYSE5122Wholesale-Drugs, Proprietaries & Druggists' Sundries0331DE6555 STATE HIGHWAY 161IRVINGTX75039UNITED STATESUS972-446-48006555 STATE HIGHWAY 161, IRVING, TX, 750396555 STATE HIGHWAY 161, IRVING, TX, 75039MCKESSON HBOC INCHealthcare1833Brian S. Tyler45,000http://mckesson.com62,700,000,000280,000,000124,384,393McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".2025-10-10 19:08:13
This is a preview of the latest data. Subscribe to access the full data.
MCK Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
MCK Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
202562,700,000,0004,900,000,0008.4775125,112,236-4,873,278-3.7491
202457,800,000,0009,600,000,00019.917129,985,514-5,616,748-4.1421
202348,200,000,00017,800,000,00058.5526135,602,262-9,763,062-6.7162
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Michele LauChief Legal Officer, Executive Vice President2025720,41703,001,093857,296647,8995,226,705
Leann B. SmithExecutive Vice President2025658,75002,200,981783,91374,2553,717,899
Brian S. TylerChief Executive Officer20251,541,667014,500,5123,669,167450,36820,161,714
Britt J. Vitaloneexecutive VicePresident20251,025,00005,000,8531,524,688131,6407,682,181
Thomas L. RodgersExecutive Vice President2025631,11701,751,295751,02979,8663,213,307
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202545,000
202451,000
202351,000
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue359,051,000,000308,951,000,000276,711,000,000
Cost Of Revenue345,728,000,000296,123,000,000264,353,000,000
Gross Profit13,323,000,00012,828,000,00012,358,000,000
Research And Development Expenses———
General And Administrative Expenses8,507,000,0008,657,000,0007,776,000,000
Operating Expenses8,901,000,0008,919,000,0007,977,000,000
Operating Income4,422,000,0003,909,000,0004,381,000,000
Net Income3,295,000,0003,002,000,0003,560,000,000
Earnings Per Share Basic25.8622.5425.23
Earnings Per Share Diluted25.7222.3925.03
Weighted Average Shares Outstanding Basic127,400,000133,200,000141,100,000
Weighted Average Shares Outstanding Diluted128,100,000134,100,000142,200,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents5,691,000,0004,583,000,0004,678,000,000
Marketable Securities Current———
Accounts Receivable25,643,000,00021,622,000,00019,410,000,000
Inventories23,001,000,00021,139,000,00019,691,000,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current55,398,000,00047,970,000,00044,292,000,000
Marketable Securities Non Current———
Property Plant And Equipment2,502,000,0002,316,000,0002,177,000,000
Other Assets Non Current3,972,000,0003,186,000,0001,992,000,000
Total Assets Non Current19,742,000,00019,473,000,00018,028,000,000
Total Assets75,140,000,00067,443,000,00062,320,000,000
Accounts Payable55,330,000,00047,097,000,00042,490,000,000
Deferred Revenue———
Short Term Debt1,191,000,00050,000,000968,000,000
Other Liabilities Current4,825,000,0004,915,000,0004,195,000,000
Total Liabilities Current61,604,000,00052,357,000,00047,957,000,000
Long Term Debt5,654,000,0005,629,000,0005,594,000,000
Other Liabilities Non Current2,659,000,0002,610,000,0001,813,000,000
Total Liabilities Non Current-61,557,000,000-52,316,000,000-47,904,000,000
Total Liabilities47,000,00041,000,00053,000,000
Common Stock3,000,0003,000,0003,000,000
Retained Earnings17,921,000,00014,978,000,00012,295,000,000
Accumulated Other Comprehensive Income-932,000,000-881,000,000-905,000,000
Total Shareholders Equity-2,074,000,000-1,971,000,000-1,857,000,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization394,000,000382,000,000360,000,000
Share Based Compensation Expense141,000,000110,000,00075,000,000
Other Non Cash Income Expense-424,000,000-233,000,000-298,000,000
Change In Accounts Receivable3,935,000,0002,954,000,0001,082,000,000
Change In Inventories2,270,000,0001,294,000,0001,259,000,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable8,301,000,0004,587,000,0003,788,000,000
Change In Other Liabilities281,000,000-37,000,000-56,000,000
Cash From Operating Activities6,085,000,0004,314,000,0005,159,000,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment859,000,000687,000,000558,000,000
Acquisition Of Business24,000,000272,000,000867,000,000
Other Investing Activities29,000,000160,000,000194,000,000
Cash From Investing Activities-733,000,000-1,072,000,000-542,000,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends352,000,000320,000,000296,000,000
Issuance Of Common Stock———
Repurchase Of Common Stock3,172,000,0003,023,000,0003,665,000,000
Issuance Of Long Term Debt498,000,000991,000,000997,000,000
Repayment Of Long Term Debt519,000,000288,000,0001,274,000,000
Other Financing Activities-554,000,000-175,000,000-324,000,000
Cash From Financing Activities-3,965,000,000-3,342,000,000-4,368,000,000
Change In Cash1,371,000,000-94,000,000744,000,000
Cash At End Of Period5,691,000,0004,583,000,0004,678,000,000
Income Taxes Paid1,124,000,000901,000,000562,000,000
Interest Paid273,000,000234,000,000224,000,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share25.8622.5425.23
Price To Earnings Ratio26.024423.801714.1122
Earnings Growth Rate14.7294-10.6619244.6721
Price Earnings To Growth Ratio1.7668-2.23240.0577
Book Value Per Share589.427506.021441.297
Price To Book Ratio1.14181.06020.8068
Ebitda5,078,000,0004,537,000,0004,730,000,000
Enterprise Value86,892,926,00072,556,468,00052,122,655,000
Dividend Yield0.00410.00450.0059
Dividend Payout Ratio0.10680.10660.0831
Debt To Equity Ratio-3.3004-2.8813-3.5337
Capital Expenditures580,000,000521,000,000445,000,000
Free Cash Flow5,505,000,0003,793,000,0004,714,000,000
Return On Equity-1.5887-1.5231-1.9171
One Year Beta0.0586-0.01810.3911
Three Year Beta0.25770.36830.6097
Five Year Beta0.49190.72070.7721
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
TYLER BRIAN S.Director, Chief Executive Officer2025-08-2211,930D4,012
TYLER BRIAN S.Director, Chief Executive Officer2025-08-1511,930D15,942
Rutledge Napoleon B JRSVP, Controller & CAO2025-08-08329D657
Wilson-Thompson KathleenDirector2025-07-30301A301
Lerman Bradley EDirector2025-07-30301A301
This is a preview of the latest data. Subscribe to access the full data.
Senate Trading
Name Of Reporting PersonType Of Reporting PersonReport DateTransaction TypeTransaction DateOwner TypeAmount
Sheldon WhitehouseSenator2017-10-12Sale (Full)2017-09-20Joint$15,001 - $50,000
Sheldon WhitehouseSenator2017-03-15Purchase2017-02-23Joint$1,001 - $15,000
Sheldon WhitehouseSenator2016-12-12Purchase2016-11-15Joint$1,001 - $15,000
Sheldon WhitehouseSenator2016-11-07Purchase2016-10-26Joint$1,001 - $15,000
Sheldon WhitehouseSenator2016-10-07Purchase2016-09-28Joint$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Valerie Hoyle2025-10-10OR04Purchase2025-09-10Spouse$1,001 - $15,000
Valerie Hoyle2025-10-10OR04Sale2025-09-23Spouse$1,001 - $15,000
Gilbert Cisneros2025-09-12CA31Sale2025-08-05—$1,001 - $15,000
Jonathan Jackson2025-08-25IL01Purchase2025-04-23Spouse$1,001 - $15,000
Jonathan Jackson2025-08-25IL01Purchase2025-03-24Spouse$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Carnegie Investment Counsel2025-09-302,136,0732,765772.54
180 WEALTH ADVISORS, LLC2025-09-30316,875410772.8659
Castle Rock Wealth Management, LLC2025-09-301,029,0421,353760.5632
Columbus Macro, LLC2025-09-30237,713308771.7955
Stockman Wealth Management, Inc.2025-09-30555,457719772.541
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
CAPITAL MANAGEMENT INVESTMENT TRUST2025-08-31Institutional SharesWSACX2,0501,407,6122.24
TRUST FOR PROFESSIONAL MANAGERS2025-08-31Column Mid Cap FundCFMCX1,087746,377.680.0749
TRUST FOR PROFESSIONAL MANAGERS2025-08-31Column Mid Cap Select FundCFMSX5,4903,769,653.60.1452
ETF Series Solutions2025-07-31Aptus Large Cap Upside ETFUPSD1,048726,829.920.881
Pacer Funds Trust2025-07-31Pacer Trendpilot US Large Cap ETFPTLC7,7765,392,967.040.1616
This is a preview of the latest data. Subscribe to access the full data.